Natixis Advisors
JAZZ icon

Natixis Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.25M Sell
21,207
-2,597
-11% -$276K ﹤0.01% 1052
2025
Q1
$2.96M Buy
23,804
+5,259
+28% +$653K 0.01% 951
2024
Q4
$2.28M Sell
18,545
-4,289
-19% -$528K ﹤0.01% 1056
2024
Q3
$2.54M Buy
22,834
+1,603
+8% +$179K 0.01% 1015
2024
Q2
$2.27M Buy
21,231
+2,054
+11% +$219K ﹤0.01% 1007
2024
Q1
$2.31M Buy
19,177
+3,752
+24% +$452K 0.01% 996
2023
Q4
$1.9M Sell
15,425
-12,690
-45% -$1.56M 0.01% 1021
2023
Q3
$3.64M Buy
28,115
+11,176
+66% +$1.45M 0.01% 806
2023
Q2
$2.1M Sell
16,939
-2,082
-11% -$258K 0.01% 948
2023
Q1
$2.78M Sell
19,021
-1,650
-8% -$241K 0.01% 856
2022
Q4
$3.29M Buy
20,671
+2,103
+11% +$335K 0.01% 795
2022
Q3
$2.48M Sell
18,568
-8,295
-31% -$1.11M 0.01% 838
2022
Q2
$4.19M Buy
26,863
+719
+3% +$112K 0.02% 700
2022
Q1
$4.07M Buy
26,144
+6,026
+30% +$938K 0.02% 745
2021
Q4
$2.56M Sell
20,118
-146
-0.7% -$18.6K 0.01% 882
2021
Q3
$2.64M Buy
20,264
+2,007
+11% +$261K 0.01% 846
2021
Q2
$3.24M Buy
18,257
+134
+0.7% +$23.8K 0.02% 761
2021
Q1
$2.98M Sell
18,123
-212
-1% -$34.8K 0.02% 759
2020
Q4
$3.03M Sell
18,335
-15,222
-45% -$2.51M 0.02% 723
2020
Q3
$4.79M Buy
33,557
+5,031
+18% +$717K 0.03% 532
2020
Q2
$3.15M Sell
28,526
-16,604
-37% -$1.83M 0.02% 659
2020
Q1
$4.5M Buy
45,130
+1,890
+4% +$188K 0.04% 483
2019
Q4
$6.46M Buy
43,240
+2,699
+7% +$403K 0.05% 441
2019
Q3
$5.2M Buy
40,541
+1,449
+4% +$186K 0.04% 464
2019
Q2
$5.57M Buy
39,092
+9,354
+31% +$1.33M 0.05% 426
2019
Q1
$4.25M Buy
+29,738
New +$4.25M 0.04% 498
2014
Q3
Sell
-5,347
Closed -$786K 1128
2014
Q2
$786K Sell
5,347
-252
-5% -$37K 0.01% 880
2014
Q1
$776K Sell
5,599
-5,110
-48% -$708K 0.01% 836
2013
Q4
$1.36M Sell
10,709
-1,248
-10% -$158K 0.02% 667
2013
Q3
$1.1M Sell
11,957
-2,114
-15% -$194K 0.02% 659
2013
Q2
$967K Buy
+14,071
New +$967K 0.02% 676